- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03394170
Pathogen Screening in OA Orthopaedic Surgical Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Osteoarthritis (OA) is the most common form of arthritis, affecting over 27 million people in the US. Rheumatoid arthritis (RA), a less common form of arthritis, is believed to differ from OA in its etiology, however both result in breakdown of cartilage. Studies have reported the association between chronic or adult periodontal disease (PD), Porphyromonas gingivalis (P. gingivalis), a gram-negative anaerobic bacterium, and rheumatoid arthritis (RA). Whether or not there is an infectious component of osteoarthritis is of significant interest.
The purpose of this study is to screen orthopedic surgery patients with and without a diagnosis of osteoarthritis for the presence of 11 pathogens associated with PD from a collection of oral rinse, synovial fluid and their synovium. The investigators hypothesize that there is a correlation between the presence of specific oral pathogens in saliva, synovial fluid and synovial tissue with clinical diagnosis of OA.
If an association between OA disease status and the presence of one or more pathogens can be confirmed, further studies can be undertaken to investigate the causative nature of oral pathogens in the clinical manifestation of OA, and eventually may lead to development of targeted therapies to prevent or slow the progression of OA.
This study will recruit 50 patients with indications for knee surgery, who fit the inclusion/exclusion criteria. Prior to surgery, patients will undergo an Institutional Review Board (IRB) approved informed consent process for in vitro cellular and biochemical characterization of their tissue. Two discreet populations, essentially normal knees and confirmed osteoarthritic knees will be studied. All patients will provide specimens for analysis, to identify the presence of oral pathogens in each participants saliva, synovial fluid and synovium.
Evaluation will include identifying the type and concentration of the following perio-pathogenic bacteria that are known to cause periodontal disease:
- Aggregatibacter actinomycetemcomitans
- Campylobacter rectus
- Capnocytophaga species (gingivalis, ochracea, sputigena)
- Eikenella corrodens
- Eubacterium nodatum
- Fusobacterium nucleatum/periodonticum
- Parvimonas micra
- Porphyromonas gingivalis
- Prevotella intermedia
- Tannerella forsythia
- Treponema denticola
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94123
- Stone Research Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Skeletally mature (as evidenced by x-ray)
- Aged 18 years or over
- Patient will be undergoing orthopaedic surgery
- If patient is "Non-OA," patient has no history of previous injury / surgery to operative joint
- Patient is able to understand the requirements of the study, abide by the restrictions, and return for all required examinations and treatments.
- Patient is able to give written informed consent
Exclusion Criteria:
- A clinical diagnosis of inflammatory arthritis made by history, examination or serology.
- An active or latent infection of the affected knee joint or any other systemic infection currently under treatment or treated within the previous 3 months.
- A history of chronic alcohol or drug abuse during the six months prior to the study.
- Clinically documented acute or unstable concomitant disease, other than the condition to be treated in this study that might affect make it difficult to interpret the patient's cartilage composition (i.e. renal, hepatic, cardiac, endocrine, hematologic, autoimmune, metabolic bone, crystal deposition, severe degenerative joint, neoplastic diseases).
- Systemic administration, within twenty days prior to the procedure, of any type of corticosteroids, antineoplastic, immunostimulating or immunosuppressant agents.
- Patients with a medical condition that interferes with their ability to participate in surgery or rehabilitation program.
- Participation in any other investigational drug or device trial during the 30 days prior to screening visit or who will receive such a drug or device during the course of this study.
- Pregnant females.
- Subject's unable or unwilling to comply with the protocol or scheduled appointments.
- Subject's unable to provide informed consent.
- Subject's unable to understand verbal and/or written English.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Osteoarthritis
Participants who are undergoing unicompartmental knee replacement will be considered OA status
|
Collection of specimens prior to and during surgery
Other Names:
|
Non-Osteoarthritis
Participants with an acute injury (occurring no more than 90 days prior to surgery) with no history of knee injury or surgery, will be considered "Non-OA" status
|
Collection of specimens prior to and during surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evidence of oral pathogens in knee joint
Time Frame: 2 weeks
|
Evidence of specified oral pathogens in the synovial fluid and/or tissue
|
2 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kevin R Stone, MD, Foundation for Sports Medicine & Arthritis Research (Stone Research Foundation)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SRF-025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on Collection of specimens prior to and during surgery
-
Aalborg UniversityAalborg University HospitalRecruiting
-
Wills EyeThomas Jefferson UniversityWithdrawnGlaucomaUnited States
-
Istituto Ortopedico GaleazziUnknown
-
Vanderbilt UniversityElement DiagnosticsCompletedBladder Cancer, BiomarkersUnited States
-
University of BernCompletedDepression Moderate | Depression MildSwitzerland
-
Institut BergoniéRecruiting
-
University of RochesterTerminated
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Turku University HospitalRecruitingHypoxia | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CarcinomaFinland
-
Lars Peter RiberOdense Patient Data Explorative Network; GCP-unit at Odense University HospitalRecruitingPostoperative Atrial FibrillationDenmark